Linked Life Data

18177447

Source:http://linkedlifedata.com/resource/pubmed/id/18177447

Statements in which the resource exists as a subject.
PredicateObject
rdf:type
lifeskim:mentions
pubmed:issue
3
pubmed:dateCreated
2008-3-17
pubmed:abstractText
Postoperative adjuvant steroid treatment is reported to improve jaundice-free survival in biliary atresia (BA) patients and to reduce the need for early liver transplantation. However, evidence of all retrospective studies is very limited, although high-dose corticosteroids were favored. The aim of this dosage finding study was to test the most promising corticosteroid protocol in a smaller but representative series, in order to optimize the settings of upcoming prospective and long-term multicenter studies.
pubmed:commentsCorrections
pubmed:language
eng
pubmed:journal
pubmed:citationSubset
IM
pubmed:chemical
pubmed:status
MEDLINE
pubmed:month
Mar
pubmed:issn
0002-9270
pubmed:author
pubmed:issnType
Print
pubmed:volume
103
pubmed:owner
NLM
pubmed:authorsComplete
Y
pubmed:pagination
712-9
pubmed:dateRevised
2009-4-6
pubmed:meshHeading
pubmed:year
2008
pubmed:articleTitle
Postoperative high-dose steroids do not improve mid-term survival with native liver in biliary atresia.
pubmed:affiliation
Department of Pedatric Surgery, Hannover Medical School, Hannover, Germany.
pubmed:publicationType
Journal Article, Clinical Trial